Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | CRHBP | P24387 | 1/20 | 0.31 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7547552 | 0.88 | ALDH1A1 (0.33) | ALDH1A1POLBMAPTKMT2AFDPS | |
| SCHEMBL8670294 | 0.81 | KDM4E (0.40) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL7544301 | 0.76 | KDM4E (0.46) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL7543660 | 0.73 | KDM4E (0.39) | ALDH1A1MAPTKDM4EGAAHPGD | |
| SCHEMBL7548035 | 0.72 | ADORA3 (0.31) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL7543629 | 0.69 | KMT2A (0.37) | ALDH1A1POLBMAPTKMT2AKDM4E | |
| SCHEMBL8908569 | 0.66 | ADRA1A (0.42) | ALDH1A1KDM4EGLAGAAHPGD | |
| SCHEMBL13497561 | 0.65 | PDE4B (0.36) | ALDH1A1POLBMAPTKDM4E | |
| SCHEMBL8729417 | 0.65 | ACHE (0.45) | — | |
| SCHEMBL7543018 | 0.64 | ADRA1A (0.71) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0883599-B1 | AMINOTETRALIN DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF | ASTRAZENECA AB (SE) | 2002-06-05 | — | — | EP | disclosed |
| EP-0883599-A1 | AMINOTETRALIN DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF | ZENECA LIMITED (GB) | 1998-12-16 | — | — | EP | disclosed |
| US-5807897-A | MUSCULAR DISORDERS | ZENECA LIMITED (GB) | 1998-09-15 | — | — | US | disclosed |
| WO-1997031887-A1 | AMINOTETRALIN DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF | ZENECA LIMITED (GB) | 1997-09-04 | — | — | WO | disclosed |